List of Excipients in API finasteride and tadalafil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing finasteride and tadalafil
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Veru Inc | ENTADFI | finasteride and tadalafil | 69681-125 | CARRAGEENAN | |
| Veru Inc | ENTADFI | finasteride and tadalafil | 69681-125 | CELLULOSE, MICROCRYSTALLINE | |
| Veru Inc | ENTADFI | finasteride and tadalafil | 69681-125 | HYPROMELLOSE | |
| Veru Inc | ENTADFI | finasteride and tadalafil | 69681-125 | LACTOSE MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for finasteride and tadalafil
Excipient focus: CARRAGEENAN
finasteride and tadalafil drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
finasteride and tadalafil drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
finasteride and tadalafil drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
finasteride and tadalafil drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
finasteride and tadalafil drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
finasteride and tadalafil drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
finasteride and tadalafil drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
finasteride and tadalafil drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
finasteride and tadalafil drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
finasteride and tadalafil drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Veru Inc | finasteride and tadalafil | 69681-125 |
| >Company | >Ingredient | >NDC |
finasteride and tadalafil drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch